STOCK TITAN

Guardant Health (GH) director exercises 4,435 RSUs and receives 2,711-unit award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Guardant Health director Manuel Hidalgo Medina reported compensation-related equity activity on June 17, 2026. He exercised vested restricted stock units to acquire 4,435 shares of Common Stock at a conversion price of $0.00 per share and received a new grant of 2,711 restricted stock units. Following these transactions, one reported line shows direct ownership of 5,074 Common Stock shares and 2,711 restricted stock units, reflecting routine vesting and grants rather than open-market trading.

Positive

  • None.

Negative

  • None.
Insider Hidalgo Medina Manuel
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units 232 $0.00 --
Exercise Restricted Stock Units 4,203 $0.00 --
Grant/Award Restricted Stock Units 2,711 $0.00 --
Exercise Common Stock 232 $0.00 --
Exercise Common Stock 4,203 $0.00 --
Holdings After Transaction: Restricted Stock Units — 5,801 shares (Direct, null); Common Stock — 871 shares (Direct, null)
Footnotes (1)
  1. The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. Not applicable for Restricted Stock Units. The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026. The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.
RSU exercises 4,435 shares Common Stock acquired via derivative exercises on June 17, 2026
New RSU grant 2,711 units Restricted Stock Units granted on June 17, 2026
Common Stock holdings 5,074 shares Direct ownership after one reported transaction line
RSU conversion price $0.00 per share Conversion or exercise price for RSU-based share acquisitions
Exercise transactions 2 entries Exercise or conversion of derivative securities (code M)
Total acquire transactions 5 entries All reported transactions show acquisitions, no dispositions
Restricted Stock Units financial
"The restricted stock unit award granted on July 17, 2024 vests over a four-year period."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Annual Meeting of Stockholders financial
"vested in full on the date of the 2026 Annual Meeting of Stockholders"
grant date financial
"vests in full on the one-year anniversary of the grant date, June 17, 2026"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hidalgo Medina Manuel

(Last)(First)(Middle)
3100 HANOVER STREET

(Street)
PALO ALTO CALIFORNIA 94304

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/17/2026M232A$0871D
Common Stock06/17/2026M4,203A$05,074D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$006/17/2026M232 (1) (2)Common Stock232$05,801D
Restricted Stock Units$006/17/2026M4,203 (3) (2)Common Stock4,203$00D
Restricted Stock Units$006/17/2026A2,711 (4) (2)Common Stock2,711$02,711D
Explanation of Responses:
1. The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter.
2. Not applicable for Restricted Stock Units.
3. The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.
4. The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.
Remarks:
/s/ John G. Saia, as attorney-in-fact for Manuel Hidalgo Medina06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Manuel Hidalgo Medina report at Guardant Health (GH)?

Director Manuel Hidalgo Medina reported equity compensation activity, exercising restricted stock units into 4,435 Common Stock shares and receiving a new grant of 2,711 restricted stock units. These transactions are routine vesting and awards, not open-market stock purchases or sales.

Did the Guardant Health (GH) director buy or sell shares on the open market?

The filing shows no open-market buying or selling. Instead, Hidalgo Medina acquired shares by exercising vested restricted stock units at a $0.00 conversion price and received a new restricted stock unit grant as part of his director compensation program.

How many Guardant Health shares did Hidalgo Medina acquire through exercises?

He acquired 4,435 Guardant Health Common Stock shares through derivative exercises coded “M.” These represent vested restricted stock units converting into shares at a stated conversion price of $0.00 per share, which is typical for stock-based compensation awards.

What new equity award did the Guardant Health director receive?

Hidalgo Medina received a new award of 2,711 restricted stock units on June 17, 2026. Each unit represents a right to receive one Guardant Health Common Stock share in the future, subject to the vesting schedule described in the award’s footnote terms.

What are Manuel Hidalgo Medina’s reported holdings after these Guardant Health transactions?

After these transactions, one reported line shows Medina directly holding 5,074 Guardant Health Common Stock shares and 2,711 restricted stock units. The filing does not indicate any remaining unexercised derivative awards beyond these newly granted restricted stock units.

How do the Guardant Health restricted stock units vest for Manuel Hidalgo Medina?

Footnotes explain two vesting structures: one grant vests 25% after one year, with the remaining 75% vesting monthly over three years, while another vests in full on the one-year anniversary of the grant date or at the next annual stockholder meeting, whichever occurs earlier.